Analysts Expect Nu Skin Enterprises, Inc. (NUS) Will Announce Quarterly Sales of $672.89 Million

Brokerages expect that Nu Skin Enterprises, Inc. (NYSE:NUS) will post $672.89 million in sales for the current quarter, Zacks reports. Four analysts have provided estimates for Nu Skin Enterprises’ earnings, with estimates ranging from $670.07 million to $675.20 million. Nu Skin Enterprises posted sales of $666.20 million in the same quarter last year, which suggests a positive year over year growth rate of 1%. The company is expected to issue its next earnings report on Thursday, February 21st.

According to Zacks, analysts expect that Nu Skin Enterprises will report full-year sales of $2.67 billion for the current financial year. For the next financial year, analysts expect that the company will post sales of $2.70 billion, with estimates ranging from $2.57 billion to $2.78 billion. Zacks’ sales averages are an average based on a survey of analysts that that provide coverage for Nu Skin Enterprises.

Nu Skin Enterprises (NYSE:NUS) last released its quarterly earnings results on Wednesday, November 7th. The company reported $0.94 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.96 by ($0.02). Nu Skin Enterprises had a return on equity of 27.50% and a net margin of 5.93%. The firm had revenue of $675.31 million for the quarter, compared to analyst estimates of $664.99 million. During the same period in the prior year, the business earned $0.76 earnings per share. Nu Skin Enterprises’s revenue for the quarter was up 19.8% on a year-over-year basis.

Several research firms have issued reports on NUS. Zacks Investment Research raised shares of Nu Skin Enterprises from a “sell” rating to a “hold” rating and set a $95.00 price target on the stock in a research note on Monday, August 6th. Tigress Financial reiterated a “buy” rating on shares of Nu Skin Enterprises in a report on Wednesday, November 21st. Jefferies Financial Group set a $98.00 price objective on shares of Nu Skin Enterprises and gave the stock a “buy” rating in a report on Friday, August 3rd. Citigroup set a $88.00 price objective on shares of Nu Skin Enterprises and gave the stock a “buy” rating in a report on Thursday, November 8th. Finally, DA Davidson started coverage on shares of Nu Skin Enterprises in a report on Tuesday, October 9th. They set a “buy” rating and a $92.00 price objective on the stock. One research analyst has rated the stock with a sell rating, two have given a hold rating and six have assigned a buy rating to the company’s stock. Nu Skin Enterprises has a consensus rating of “Buy” and a consensus target price of $86.29.

In other news, General Counsel D Matthew Dorny sold 2,500 shares of the stock in a transaction dated Monday, October 1st. The shares were sold at an average price of $82.18, for a total transaction of $205,450.00. Following the transaction, the general counsel now directly owns 33,871 shares in the company, valued at approximately $2,783,518.78. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Over the last quarter, insiders have sold 7,500 shares of company stock worth $568,550. Insiders own 5.20% of the company’s stock.

Several hedge funds have recently made changes to their positions in NUS. BlackRock Inc. lifted its holdings in shares of Nu Skin Enterprises by 11.5% during the 2nd quarter. BlackRock Inc. now owns 6,143,407 shares of the company’s stock worth $480,352,000 after acquiring an additional 635,246 shares during the period. Los Angeles Capital Management & Equity Research Inc. raised its holdings in Nu Skin Enterprises by 410.1% in the third quarter. Los Angeles Capital Management & Equity Research Inc. now owns 427,800 shares of the company’s stock valued at $35,259,000 after buying an additional 343,935 shares during the period. Renaissance Technologies LLC raised its holdings in Nu Skin Enterprises by 51.1% in the second quarter. Renaissance Technologies LLC now owns 814,000 shares of the company’s stock valued at $63,647,000 after buying an additional 275,200 shares during the period. Assenagon Asset Management S.A. raised its holdings in Nu Skin Enterprises by 524.5% in the third quarter. Assenagon Asset Management S.A. now owns 295,551 shares of the company’s stock valued at $24,359,000 after buying an additional 248,222 shares during the period. Finally, Point72 Asset Management L.P. purchased a new position in Nu Skin Enterprises in the third quarter valued at approximately $12,882,000. Institutional investors and hedge funds own 76.52% of the company’s stock.

Shares of Nu Skin Enterprises stock traded up $0.30 during mid-day trading on Monday, hitting $65.97. 269,284 shares of the stock were exchanged, compared to its average volume of 336,484. Nu Skin Enterprises has a twelve month low of $60.60 and a twelve month high of $88.68. The stock has a market capitalization of $3.65 billion, a P/E ratio of 20.42, a P/E/G ratio of 1.67 and a beta of 1.04. The company has a debt-to-equity ratio of 0.44, a current ratio of 1.93 and a quick ratio of 1.25.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 12th. Stockholders of record on Friday, November 30th will be issued a dividend of $0.365 per share. The ex-dividend date is Thursday, November 29th. This represents a $1.46 annualized dividend and a dividend yield of 2.21%. Nu Skin Enterprises’s payout ratio is currently 45.20%.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems and targeted treatment products, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic, personal care, and hair care products.

See Also: Risk Tolerance

Get a free copy of the Zacks research report on Nu Skin Enterprises (NUS)

For more information about research offerings from Zacks Investment Research, visit

Earnings History and Estimates for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with's FREE daily email newsletter.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit